Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: Editorial from Guest Editor [ Hot Topic:Current Status of Therapeutics and Preventive Measures for Patients with Thalassaemia and Sickle Cell Disease (Guest Editor: P.H. Reddy)]
Volume: 10 Issue: 1
Author(s): P. Hemachandra Reddy
Affiliation:
Export Options
About this article
Cite this article as:
Hemachandra Reddy P., Editorial from Guest Editor [ Hot Topic:Current Status of Therapeutics and Preventive Measures for Patients with Thalassaemia and Sickle Cell Disease (Guest Editor: P.H. Reddy)], Cardiovascular & Hematological Agents in Medicinal Chemistry 2012; 10 (1) . https://dx.doi.org/10.2174/187152512799201154
DOI https://dx.doi.org/10.2174/187152512799201154 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Terebinthus atlanticus on Glucose Metabolism in Diabetic Rats
Cardiovascular & Hematological Disorders-Drug Targets Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain
Endocrine, Metabolic & Immune Disorders - Drug Targets Amyloid-β Immunotherapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Pharmacological Strategies that Affect HIF-1 in the Ischemic Brain: Focus on Hydroxylases Activity and Protein Kinase Pathways
Current Signal Transduction Therapy Synthesis, Anticonvulsant and Antimicrobial Activities of Some New [1-(2-Naphthyl)-2-(pyrazol-1-yl)ethanone]oxime Ethers
Medicinal Chemistry Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration
Current Drug Targets Overview of Dietary Influences on Atherosclerotic Vascular Disease:Epidemiology and Prevention
Cardiovascular & Hematological Disorders-Drug Targets Formulation and In Vivo Evaluation of Ticagrelor Self-nanoemulsifying Drug Delivery Systems
Pharmaceutical Nanotechnology Editorial (Thematic issue: “Alkaloids in Nature: Synthesis, Isolation and Pharmacological Applications” Part 1)
Current Topics in Medicinal Chemistry Heat Stress Nephropathy: What Have We Learned?
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Antiobesity Effect of Biochanin-A: Effect on Trace Element Metabolism in High Fat Diet-Induced Obesity in Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial [ Progress of ‘Current Alzheimer Research’ and Update on Roles of Lipids, Estrogen,Neurotrophins and Cytokines in Alzheimers Disease ]
Current Alzheimer Research What is the Current Role for Vitamin D and the Risk of Stroke?
Current Neurovascular Research Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration
Coronaviruses From Cerebrospinal Fluid Pulsation to Noninvasive Intracranial Compliance and Pressure Measured by MRI Flow Studies
Current Medical Imaging Diabetes Mellitus and Bell’s Palsy
Current Diabetes Reviews A Review of Recent Patents on Micro-Combustion and Applications
Recent Patents on Engineering Clinical Uses of 22-Oxacalcitriol
Current Vascular Pharmacology PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
Current Pharmaceutical Design